•  
  •  
 

Central Asian Journal of Medicine

Article Title

METASTATIC BREAST CANCER

Abstract

Breast cancer is the most common cause of death among women from malignant tumors. Metastatic breast cancer is not currently a curable disease. According to most authors, especially in developing countries, from 50 to 70% of patients already have advanced forms of the disease upon admission (locally common forms, in the form of lesions of regional lymph nodes and distant metastases to various organs). The nature and frequency of distant breast cancer metastases is very diverse. In 40-80% of cases, breast cancer metastasizes to bone. However, it can metastasize other organs and systems, for example, to the liver, lungs, ovaries, brain, and others. Diagnosis and treatment of distant breast cancer metastases is an urgent problem in oncammammology, since mortality in these forms remains very high, and the long-term and immediate results of treatment are still very unsatisfactory. The conducted therapy, being palliative, is aimed at improving "quality" and prolonging life. The most effective for conducting palliative therapy for this group of patients is various chemotherapy regimens. But traditionally used chemotherapy regimens do not always turn out to be effective; on the contrary, cytostatics weaken the body’s resistance and deplete the body’s immunobiological reserve, sometimes they worsen not only the quality of life, but also shorten the duration.

First Page

23

Last Page

46

References

1. Abashin S.Yu. Neoadjuvant systemic therapy in the complex treatment of locally advanced breast cancer // Sovrem, Onkol .. - 2000. - T.2 - No. 4 - P. 23 - 29. 2. Artamonova E.V. The use of a combination of carboplatin, doxorubicin and 5-fluorouracil in the preoperative chemoradiation treatment of locally advanced breast cancer. / Artamonova E.V., Manzyuk L.V., Khailenko V.A. et al. // Russian. honey. magazine. - 2003. - T. 11 - No. 26 - S. 45 - 52. 3. Bahlaev I.E. The state of diagnosis of breast cancer in the Karelian Autonomous Soviet Socialist Republic / Bahlaev I.E., Tolpinsky A.P., Novikova A.M., Bedov V.M. // Theses of the All-Union Symposium "Screening in the early detection of tumors of the reproductive system and organ-preserving treatment. Kostroma, June 5-6, 1991. - L., 1991. - P.5. 4. Balla A. A. Ultrasound diagnosis of lesions of regional lymph nodes in breast cancer / Balla A. A., Fomin K. A., Ovchinnikov V. A., Chernetsov A. A. // Radiation Diagnostics News - 1999. - No. 3 - S. 11 - 22. 5. Bazhenova A.P. Mammary cancer. / Bazhenova A.P., Ostrovtsev L.D., Khakhanashvili G.N. M.: Medicine. 1985. - 272s. 6. Bergh J. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomised trial-Scandinavian Breast Group 9401 study /Bergh J., Wiklund Т., Erikstein B. et al. // Lancet. - 2001. - V. 356. -P.1384-1391. 7. Bergh J. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomized trial. Scandinavian breast group 9401 study /Bergh J., Wiklund Т., Erikstein B. et al. // Lancet. - 2000.-V. 356.-P. 1384-1391. 8. Blokhin S.N. On the issue of primary plastic surgery for breast cancer with own tissues / Blokhin S.N., Laktionov K.P., Portnoy S.M. and others // Vestn. ONTS RAMS, 1994, App. - S. 55-57. 9. Blokhin S.N. Reconstructive plastic surgery for breast cancer / Abstract. diss .... doctor of medical sciences, M., 2002 .-- 34 p. 10. Boccardo F. Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial /Boccardo F., Rubagotti A., Amoroso D. et al: // J Clin Oncol. - 2000. - V. 18.-P. 2718-2727. 11. Bonadonna G. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up /Bonadonna G., Valagussa P., Moliterni A. et al. // N Engl J Med. 12. Boxer D.I. Bone secondaries in breast cancer: the solitary metastasis /Boxer D.I:, Colin E.C., Coleman R., Fogelman I. // J Nuc Med. - 1989. - V. 30.-P. 1318-1320. 13. Breast Cancer: Cancer and Leukemia Group B, Trial 9342 //Journal of Clinical Oncology. -2004. -№22. - P. 2061-2068 14. Bria E. Impact of taxanes in association with anthracyclines in 1 st line chemotherapy for metastatic breast cancer: Comprehensive review of 2805 patients in 7 phase III trials /Bria E., Nistico C., Cuppone F. et al. // Proc. ASCO. - 2004. - Vol. 23. - Abstr. 659. 15. Burdina L.M. Radiothermometry in the algorithm for a comprehensive examination of the mammary glands / Burdina L.M., Pinhosevich E.G., Khailenko V.A. and others // Modern Oncology - 2004. - T.6 - No. 1 - C. 16. Buric M. Metastatic dissemination in the inflammatory breast cancer (IBC) /Buric M., Filipovic S., Projevic M., Veselinovic S. // Eur. J. Cancer.1996. - V.32A. - Suppl. - P. 8-22. 17. Burstein H. Docetaxel Administered on Weekly Basis for Metastatic Breast Cancer. Burstein H., Manola J., Younger J. et al. // J. Clin. Oncol. - 2000.-V. 18.-P. 1212-1219. 18. Cabanes P.A. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie /Cabanes P.A., Salmon R.J., Vilcoq J.R., et al. // Lancet. - 1992. - V.339. - P.1245-1248. 19. Camarli Z.P. Features of the spread of malignant tumors in the Kyrgyz Republic. // Actual problems of oncology and radiology. Sat scientific works. Bishkek - 2003 .-- P.5-11. 20. Catroppo J.F., Lara J.F. Metastatic metaplastic carcinoma of the breast: an uncharacteristic patterns // Diagn Cytopathol. - 2001. - Vol. - 25.-№5.-P.-285 -291. 21. Colozza M. Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results /Colozza M., Gori S., Mosconi A.M. et al. // Am. J. Clin. Oncol. - 1996. - V. 19. - N 1. - P.10-17. 22. Coombes R.C. A randomized trial of exemestan after two or three years of tamoxifen therapy in postmenopausal women with primary breast cancer /Coombes R.C., Hall E., Gibson L.J. et al. // New. Engl. J. Med. - 2004. - Vol. 350. - P. 1081-1092. 23. Coskun U. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer /Coskun U., Gunel N., Onuk E. et al. // Neoplasma. - 2003. - V. 50. - N 3. - P. 210-216. 24. Cuzick J. Future possibilities in the prevention of breast cancer: Breast cancer prevention trials. // Breast Cancer Res. - 2000. - V. 2. - P. 258-263. 25. Darby S. Mortality from cardiovascular disease after radiotherapy for breast cancer, in 298885 women registered in the SEER cancer registries /Darby S., McGale P., Peto R. // 27 th Annual San Antonio Breast Cancer Symposium.. - 2004. - Vol. 88. - Suppl. - Abstr. 32. 26. Davydov G.A. Possibilities of scintigraphy and SPECT with 99шЕс - technetril in the diagnosis of relapse of breast cancer / Davydov GA, Smirnova IA, Pekshina TV // Thesis. doc. II Congress of Ross. Society for Nuclear Medicine, 2000, Moscow, p. 48. 27. Demidov V.P. Mammary cancer. Combined and complex treatment of patients with malignant tumors / Demidov V.P., Ostrovtsev L.D., Volkova H.A .. Ase N.Ya. // Ed. IN AND. Chissova. - M .: Medicine, 1989 .-- S. 207-235. 28. Demidov V.P. The use of a carbon dioxide laser in the surgical treatment of breast cancer / Demidov V.P., Rykov V.I., Putyrsky L.A., Lak D.D. // Q. onkol. - 1992.-№1. -FROM. 42-50. 29. Diagnosis and treatment of breast cancer. / Ed. V.P. Demidova. -M.: Medicine. 1985: - 172 p. 30. Dvoirin V.V. Statistics of breast cancer Bulletin ONC RAMS. - 1994. - No. 1. - S. 3-12 31. Dymarsky L. 10. Mammary cancer. -M .: Medicine, 1980 .-- 200 p. 32. Elangovan A.E. Predicting sentinel node involvement: Manchester experience. Breast Cancer Research Treatmen /Elangovan A.E., Wilson M., Knox F.W. et al. //Special Issue: 24th Annual San Antonio Breast Cancer Symposium. - 2001. - V.69. - P.220. - Abstract 114. 33. Ermilova V.D. ' The role of modern pathomorphology in the characterization of breast cancer. // Pract. onkol. - 2002. - t. 3, No. 1.- S. 15-20. 34. Ferlicot S. Wide metastatic spreading in infiltrating lobular carcinoma of the breast /Ferlicot S., Vincent-Salomon A., Medioni J. et al. II Eur J Cancer. - 2004. - V.40 (3). - P. 336-41. 35. Fleming F.J. Factors affecting metastases to non-sentinel lymph nodes in breast cancer /Fleming F.J., Kavanagh D., Crotty T.B. // J Clin Pathol. - 2004.- Jan. 57 (1). -P.73-6. 36. French Adjuvant Study Group: Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant 37. Frolov I.M. "Interventional radiology" in the study of mammary glands. // Questions of oncology - 2000. - T. 46 .- No. 6 .. - S. 682 -695. 38. Fumoleau P. A randomized phase II study of 4 or 6 cycles of Adriamycin/Taxol as neoadjuvant treatment of breast cancer. Breast Cancer Research and Treatment /Fumoleau P., Tubiana-Hulin M., Romieu G. et al. Special issue: 24th Annual San Antonio Breast Cancer Symposium. — 2001. - V. 69. - P.298 Abstract 508. 39. Gershtein E.S. Tissue markers as prognostic factors for breast cancer. // Practical Oncology - 2002. - T.Z. - No. 1 - S. 38-44. 40. glands. // Pract. onkol. - 2002. - t. 3 - No. 1. - S. 45 - 51. 41. Goldhirsch A. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer /Goldhirsch A., Glick G.H., Gelber R.D., Coates A.S., Senn H.J. // J Clin Oncol - 2001. - V. 19. - P. 3817¬3827. 42. Goldhirsch A. Meeting highlights: International consensus panel on the treatment of primary breast cancer /Goldhirsch A., Glick J.H., Gelber R.D. et al: // J Natl Cancer Inst. - 1998. - V. 90. - P. 1601-1608. 43. Goldhirsch A. Taxanes as adjuvant for breast cancer /Goldhirsch A., Francis P., Castiglione-Gertsch M., et al. // Lancet. - 2000. - V. 356. - P. 507. 44. Goldobenko G.V. On the problem of organ-preserving treatment of patients with early stage breast cancer / Goldobenko G.V., Mikhina Z.P., Magali Yahya and others // Vopr. onkol. - 2000. - T. 46, No. 6 - S. 704-707. 45. Goss P.E. A randomized Trial of Letrozol in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer /Goss P.E., Ingle J.N., Martino S. et al. // New. Engl. J. Med. - 2003. - Vol. 349. - N. 19.-P. 1793-1802. 46. Gradishar W. J. Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study Gradishar W. J., Meza L. A., Amin B. et al. // Journal of Clinical Oncology. - 2004. - №. 22. - P. 2321-2327 47. Graham M. Dose-intensive sequential adriamycin (A) and iv CMF (A>CMF) with G-CSF (G) support for stage II and III breast cancer (BrCa): a feasible and effective outpatient regimen /Graham M., Gonzalez P., Cance W. et al. // Proc. Am. Soc. Clin. Oncol. - 1996. - Vol. 15. - P. 137. 48. Hanson K.P. From molecular to clinical oncology. Oncogen ERBB2 / HER2. / Hanson K.P., Imyanitov E.H. // Questions of oncology - 2002 - T. 48. - No. 2. - S. 137 - 144. 49. Ivanov V.G. Epidemiological risk factors, early diagnosis of breast cancer. // Pract. onkol. - 2002. - t. 3, No. 1. -C. 1-5. 50. Kanaev S.V. The role of radiation therapy in the treatment of breast cancer 51. Kanevtsov VV Optimization of approaches to the diagnosis and treatment of breast diseases. // Training method. allowance. M. - 2001 .-- 63 s. 52. Karimov P.A. Clinical evaluation of prognosis factors in stage III breast cancer. / Abstract of diss. ... Ph.D. M., 1989. 53. Karimov P.A. Diagnosis of breast cancer. // Materials V Ros. Oncological Conf., November 27-29, 2001, Moscow - S. 67 - 73. 54. Kharchenko V.P. et al. Correlation of the clinical effect of tumor cell pathomorphism and long-term results of complex treatment of patients with locally advanced breast cancer // Vopr. onkol. - 2000. - T. 46, No. 6. - S. 740 - 743. 55. Korytova L.I. Radiation therapy of advanced and metastatic breast cancer / Korytova L.I., Khazova T.V., Zhabina V.M. // Pract. onkol. - 2000. - No. 2 (June) - S. 46-49. 56. Kudryavtsev D.V. Radiation therapy of breast cancer / Kudryavtsev D.V., Gumenetskaya Yu.V. // Materials VI Ros. Oncological Conf., November 26-28, 2002, Moscow - S. 112 - 123. 57. Kushlinsky N.E. Modern possibilities of molecular biochemical methods for assessing the biological "behavior" of breast cancer / Kushlinsky N.E., Gershtein E.S. // Vestn. RAMS. - 2001.-№9.-S. 65-70. 58. Letyagin V.P. Primary breast tumors. A practical guide to treatment // M. - "Miklosh" - 2004. - 331 p. 59. Manzyuk L.V. Combined treatment of locally advanced breast cancer // Vopr. onkol. - 2001. - T. 47. - N6 - S. 740 - 743. 60. Mistakopulo M.G. High-dose chemotherapy in the complex treatment of infiltrative-edematous forms of breast cancer / Mistakopulo MG, Laktionov KP, Ptushkin VV et al. // VII Russian Oncological Congress. November 25-27, 2003, Moscow. M., 2003 .-- S. 235-236 61. Moiseenko V.M. The natural history of breast cancer growth // Pract. onkol. - 2002. - T.Z., No. 1 - S. 6-14. 62. Nechushkin M.I. Videothoracoscopic parasternal lymphadenectomy in the diagnosis of breast cancer / Nechushkin M.I., Bekuzarova N.V., Trigolosov A.B. et al. // Modern Oncology. 63. Nests A.B. Mental changes in cancer patients // Pract. onkol. - 2001.-№1 (5) - S. 5 - 13. 64. Orlova R.V. The principles of drug treatment of patients with disseminated breast cancer / Orlova R.V., Moiseenko V.M. / Practice. - 2000 - No. 2. - S. 19-21. 65. Pak D. D. From superradical mastectomy to organ-preserving operations // Materials V Ros. oncologist. conf. 27 66. Potapov C.JT. Outpatient experience with arimidex in patients with advanced breast cancer in menopause / Potapov C.JL, Kapitanova ET // Modern oncology. - 2000. - "D 2. - N 2-C. 46 - 61. 67. Prokopenko S.P. Invasive radiology in the diagnosis and treatment of benign breast diseases // Oncology Issues - 2000. - T. 46. - No. 6. - S. 693 - 698. 68. Putyrsky J1.A. Breast Cancer // Minsk - “Higher School” -2003. -95 p. 69. Semiglazov V.F. The changing role of surgical and systemic treatment for resectable breast cancer. // Materials VI Ros. Oncological Conf., November 26-28, 2002, Moscow - S. 67 - 80. 70. Semiglazov V.V. In situ carcinoma of the mammary gland morphological and clinical problems // Pract. onkol. - 2002. - T. 3 .- No. 1.-S. 60-68. 71. Semiglazov VV The value of prognostic and predictive factors when choosing treatment in patients with metastatic breast cancer // Pract. onkol. - 2000. - No. 2 (June). - S.26 - 30. 72. Shifts A.M. On the place of radiothermometry in mammological practice / Sdvizhkov A.M., Vesnin S.G., Kartasheva A.F. et al. // Actual problems of mammology. - 2000. - S.28-40. 73. Sinyukova G.T. Ultrasound diagnosis of neoplasms of the chest wall and mediastinum / Sinyukova G.T., Sholokhov V.N., Gudilina E.A. //Ultrasound diagnostics. - 2000. - No. 4. - S. 89-97. 74. Slapik S. S. Priorities for the use of computed tomography in the diagnosis of diseases of the chest. / Slapik S.S., Davidovich T.V. // News of radiation diagnostics - 2000.-№ 1 - P. 20-22. 75. Starinsky VV The incidence of the population of Russia malignant neoplasms in 2000 // Ros. onkol. zhur. - 2002.-No3.-S. 39-44. 76. Stenina M.B. Hormone therapy for disseminated breast cancer. // Pract. - 2000. - No. 2. - S. 12 - 18. 77. Stenina M.B. Promising directions for the development of drug therapy for breast cancer // Prak.onkol. - 2002 - T.Z-No. 4.-S.262-272. 78. Study Group 05 randomized trial. // J Clin Oncol. - 2001. - V.19. - P. 602¬611. 79. Tailor S.M. The experience of treating patients with prognostically burdened locally advanced breast cancer / Tailor S.M., Laktionov K.P., Barkanov A.I. and others // IV annual Russian oncological conference November 21-23, 2000, Moscow. M., 2000 .-- S. 57-59 80. Tailor S.M. The role of the surgical method in the treatment of locally advanced and disseminated breast cancer. 81. Talakhadze N.T. Non-invasive preoperative diagnosis of breast cancer metastases in the parasternal lymph nodes. / Talakhadze N.T., Yechushkin M.I., Nisnevich L.A. and others // Radiology practice. - 2002. - No. 3. - S. 22-27. 82. Turliman V. Hormonal treatment of breast cancer. // Materials VI Ros. oncological conference., November 26-28, 2002. Moscow -S. 89-95. 83. Tyulyadin S.A. Chemotherapy of disseminated breast cancer // Prak.onkol. ' - 2000. - No. 2. - S.Z-11. 84. Urmancheeva A.F. Problems of fertility, contraception and menopausal replacement therapy in patients after breast cancer treatment / Urmancheeva AF, Kutusheva GF // Pract. - 2002. - T.Z.-No.1. - S. 52 - 59. 85. Vishnevsky A.A. Breast plastic surgery. / Vishnevsky A.A., Kuzin M.I., Olenin V.P. // M .: Medicine, 1987 .-- 224 p. 86. Vozny E.K. and others. Some prognostic factors in the complex treatment of locally advanced breast cancer // Vopr. onkol. - 2000. - T. 46 - No. 6 - S. 732-736. 87. Zaridze D.G. Epidemiology and screening of breast cancer // Oncology issues. - 2002. - T. 48 - No. 4-5 - S. 489-495. 88. Zavizion V.F. Ways to improve the results of organ-preserving treatment of patients with breast cancer / Zavizion V.F., Kose V.A., Mashtaler V.E. and others // Oncology - 2001. - T.Z. - No. 2-3. 89. Zvezdina K.Yu. Differential diagnosis of palpable soft tissue seals after radiation therapy / Zvezdina K.Yu., Khmelevsky EV, Minh N.V. et al. // Bulletin of the Russian Science and Technology Center of the Ministry of Health of the Russian Federation - No. 3 - P. 5-12.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.